Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evolus Inc
(NQ:
EOLS
)
15.75
-0.11 (-0.69%)
Streaming Delayed Price
Updated: 3:01 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Evolus Inc
< Previous
1
2
3
Next >
EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024
July 31, 2024
EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early
July 31, 2024
The company reported $1.1 million in adjusted operating income, well ahead of expectations for a $2.6 million loss.
Via
Investor's Business Daily
Evolus: Chiseling Away At The Aesthetic Market
May 25, 2024
Via
Talk Markets
EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
EOLS stock results show that Evolus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 02, 2024
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
Via
InvestorPlace
Recap: Evolus Q4 Earnings
March 07, 2024
Via
Benzinga
Earnings Outlook For Evolus
March 06, 2024
Via
Benzinga
AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
February 14, 2024
A Relative Strength Rating upgrade for AbbVie shows improving technical performance.
Via
Investor's Business Daily
Earnings Preview: Evolus
August 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 21, 2024
Via
Benzinga
EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023
March 07, 2024
EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings
February 01, 2024
Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level.
Via
Investor's Business Daily
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 29, 2024
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped...
Via
Benzinga
5 Analysts Have This to Say About Evolus
July 28, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday
January 29, 2024
U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Alternative Maker
January 17, 2024
Evolus beats Q4 revenue expectations, up 40% YoY at $61M. Full-year 2023 hits $202M, exceeding guidance. Analysts bullish on Evolus.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 17, 2024
Via
Benzinga
Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition
January 11, 2024
AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing...
Via
Benzinga
Exposures
Product Safety
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to...
Via
Benzinga
Exposures
Product Safety
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 08, 2023
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.
Via
Benzinga
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
November 08, 2023
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 08, 2023
Via
Benzinga
Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
November 08, 2023
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 07, 2023
Via
Benzinga
7 Must-Own Small-Cap Stocks That Could Outperform the Market
October 08, 2023
If you’re ready to absorb significant risk for the chance of ridiculous upside, these small-cap stocks to buy may be just for you.
Via
InvestorPlace
7 Small-Cap Stocks Analysts Predict Will Double in 2024
September 13, 2023
While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors.
Via
InvestorPlace
Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying
August 16, 2023
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 27, 2023
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.